Skip to main content

Table 1 Demographics

From: Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients

Gender

8 F, 22 M

Age, years

57 (25 to 93)

Baseline pUA, mg/dL

10.8 ± 1.2 (9.0 to 13.7)

Tophi, chronic gout arthritis

28 (93%)

Wt, kg

95.0 ± 31.2 (44 to 203)

BMI

31.5 ± 7.5 (19 to 56)

Serum creatinine, mg/dL

1.9 ± 0.7 (0.8 to 3.2)

Most frequent comorbidities

 

Osteoarthritis

4 (13%)

Hypertension

27 (90%)

Diabetes

12 (40%)

Cardiovascular disease

14 (47%)

  1. BMI, body mass index; pUA, plasma urate concentration.